转自：北京日报客户端 净利下滑之下，倍杰特祭出重组计划。11月19日晚间，倍杰特发布公告称，全资子公司拟以自有资金或 自筹资金约2.25亿元收购文山州大豪矿业开发有限公司（以下简称"大豪矿业"）55%股权。受该消息影 响，11月20日，倍杰特收于涨停价20.8元/股。不过，筹划并购背后，标的公司大豪矿业目前尚未盈利， 此外，截至10月31日，大豪矿业债务总额近2亿元。 重组消息刺激股价涨停 11月20日，倍杰特高开高走，封上涨停板。 倍杰特表示，本次收购属于上下游产业链并购，核心目的是打通产业链上下游，提升整个产业链条的效 率和抗风险能力。本次交易后，标的公司将成为公司控股子公司，公司将通过标的公司开展矿产开采及 加工业务。 中关村物联网产业联盟副秘书长袁帅告诉北京商报记者，公司借助并购来整合产业链，这种战略布局有 助于提升公司抗风险能力，为公司未来发展开辟新的增长点，增强公司综合竞争力。 倍杰特新材料则设立于今年2月19日。据倍杰特2025年半年报，该公司为获取盐湖资产市场设立，尚未 实现损益。 标的公司债务显眼 公告显示，大豪矿业尚未盈利。财务数据显示，2024年、2025年1—7月，大豪矿业营收均为0元 ...

净利下滑之下，倍杰特祭出重组计划。11月19日晚间，倍杰特发布公告称，全资子公司拟以自有资金或 自筹资金约2.25亿元收购文山州大豪矿业开发有限公司（以下简称"大豪矿业"）55%股权。受该消息影 响，11月20日，倍杰特收于涨停价20.8元/股。不过，筹划并购背后，标的公司大豪矿业目前尚未盈利， 此外，截至10月31日，大豪矿业债务总额近2亿元。 重组消息刺激股价涨停 11月20日，倍杰特高开高走，封上涨停板。 交易行情显示，11月20日，倍杰特高开5.02%，随后股价迅速拉升至涨停，最终收于涨停价20.8元/股， 当日成交金额约6.06亿元，总市值85.02亿元。 消息面上，倍杰特披露公告称，公司全资子公司倍杰特（北京）新材料科技有限公司（以下简称"倍杰 特新材料"）拟以自有资金或自筹资金约2.25亿元收购汤玮、龙岩市小娘坑矿业有限公司、王育才合计 持有的大豪矿业55%股权。本次交易完成后，大豪矿业纳入倍杰特合并报表范围。本次交易不构成关联 交易，也不构成重大资产重组。 倍杰特新材料则设立于今年2月19日。据倍杰特2025年半年报，该公司为获取盐湖资产市场设立，尚未 实现损益。 标的公司债务显眼 公告显示， ...

Group 1 - The company Wanbangda (SZ 300055) held its sixth second board meeting on August 25, 2025, via telephone to discuss organizational adjustments [1] - For the first half of 2025, Wanbangda's revenue composition was as follows: petrochemicals accounted for 90.05%, industrial water treatment for 48.58%, and solid waste treatment services for 5.77%, with inter-segment eliminations at -44.4% [1] - As of the report, Wanbangda's market capitalization was 5.5 billion yuan [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to rising stock prices for industry-listed companies [1]

Core Viewpoint - The recent financial report of Jingyuan Environmental Protection (688096) shows significant growth in revenue and net profit, although there are concerns regarding high accounts receivable and a decline in quarterly net profit [1] Financial Performance Summary - Total revenue for the first half of 2025 reached 210 million yuan, a year-on-year increase of 23.03% [1] - Net profit attributable to shareholders was 2.32 million yuan, up 157.27% from the previous year [1] - The gross profit margin improved to 27.68%, an increase of 1.69% year-on-year [1] - The net profit margin turned positive at 1.64%, a significant increase of 169.6% compared to the previous year [1] - The total of selling, administrative, and financial expenses was 51.55 million yuan, accounting for 24.54% of revenue, down 11.98% year-on-year [1] Accounts Receivable and Cash Flow - Accounts receivable amounted to 736 million yuan, representing 154.62% of the latest annual revenue [1] - The company reported a significant increase in operating cash flow, with a year-on-year growth of 169.65% [6] - The cash flow from operating activities turned positive, attributed to improved collection mechanisms and stable cash flow from the computing power sector [6] Changes in Assets and Liabilities - Prepayments decreased by 31.41% due to supplier deliveries [2] - Investment properties increased by 49.06% as properties were converted from self-use to investment [2] - Long-term deferred expenses rose by 83.18% due to new outsourced R&D costs [2] - The company’s interest-bearing liabilities decreased by 18.24% to 628 million yuan [1] Business Strategy and Future Outlook - The company is focusing on expanding its core business and exploring new areas in industrial water treatment and computing power markets [5] - The management aims to improve performance by addressing issues related to accounts receivable and enhancing operational efficiency [10] - The company is also pushing forward with the "Environmental Protection + AI" initiative to create new growth drivers [10]

Group 1 - The company Wanbangda (SZ 300055, closing price: 6.27 yuan) held its sixth board meeting on July 30, 2025, to discuss the appointment of a securities affairs representative [2] - For the year 2024, Wanbangda's revenue composition is as follows: petrochemicals account for 82.29%, industrial water treatment for 10.41%, solid waste treatment services for 6.77%, and financial investments for 0.53% [2]